Healthcare Sector Articles Healthcare Sector Articles - Page 2 April 9, 2026 12:00 PM ET3 Dividend Aristocrats Whose Yields Can Help Combat InflationChris MarkochNYSE:AMCRNYSE:CVXNYSE:ABBVRead 3 Dividend Aristocrats Whose Yields Can Help Combat InflationApril 7, 2026 10:45 AM ETA Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?Jeffrey Neal JohnsonNYSE:ABTRead A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?April 2, 2026 10:15 AM ETLilly's Next Empire: A $10 Billion Bet on AI and NeuroscienceJeffrey Neal JohnsonNYSE:LLYRead Lilly's Next Empire: A $10 Billion Bet on AI and NeuroscienceApril 2, 2026 6:55 AM ETPhreesia Hits Bottom in Q1: Rebound Ahead, Timing UncertainThomas HughesNYSE:PHRRead Phreesia Hits Bottom in Q1: Rebound Ahead, Timing UncertainMarch 31, 2026 5:58 AM ETMerck Just Made a Big Bet on a New Cancer Growth Engine Jessica MitacekNYSE:MRKNYSE:LLYNYSE:ABBVRead Merck Just Made a Big Bet on a New Cancer Growth Engine March 29, 2026 7:07 AM ETThe Often-Missed Corner of Healthcare That Wall Street Is LovingNathan ReiffNYSE:TMONYSE:DHRNYSE:ARead The Often-Missed Corner of Healthcare That Wall Street Is LovingMarch 24, 2026 2:15 PM ETWhy Boston Scientific's Big Dip Could Be a Bigger OpportunityNathan ReiffNYSE:BSXRead Why Boston Scientific's Big Dip Could Be a Bigger OpportunityMarch 16, 2026 5:44 AM ET3 Companies at the Forefront of the GLP-1 Pill WarsNathan ReiffNYSE:LLYNASDAQ:VKTXNASDAQ:GPCRRead 3 Companies at the Forefront of the GLP-1 Pill WarsMarch 15, 2026 8:05 AM ET3 Stocks That Could Be Next to Announce a Stock SplitChris MarkochNASDAQ:KLACNYSE:LLYNYSE:MCKRead 3 Stocks That Could Be Next to Announce a Stock SplitMarch 15, 2026 6:19 AM ETEli Lilly’s Employer Push Could Unlock New GLP-1 DemandLeo MillerNYSE:LLYNYSE:NVORead Eli Lilly’s Employer Push Could Unlock New GLP-1 DemandMarch 13, 2026 10:22 AM ETThe Real Reason Eli Lilly Is Pouring $3 Billion Into ChinaJeffrey Neal JohnsonNYSE:LLYNYSE:NVORead The Real Reason Eli Lilly Is Pouring $3 Billion Into ChinaMarch 12, 2026 1:24 PM ETWhy 2 Small Biotechs May Hold the Key to New Cancer TreatmentsNathan ReiffNASDAQ:IOVANASDAQ:IBRXRead Why 2 Small Biotechs May Hold the Key to New Cancer TreatmentsMarch 10, 2026 12:03 PM ETPatience Pays: Hims & Hers Surges on News of Novo Nordisk DealJordan ChusslerNYSE:HIMSNYSE:NVORead Patience Pays: Hims & Hers Surges on News of Novo Nordisk DealMarch 8, 2026 6:00 AM ETThe Aging of America Could Make HCA Healthcare a Long-Term WinnerNathan ReiffNYSE:HCARead The Aging of America Could Make HCA Healthcare a Long-Term WinnerMarch 7, 2026 6:49 AM ET3 Undervalued Names Too Cheap to IgnoreNathan ReiffNYSE:MRKNASDAQ:CPBNYSE:USFDRead 3 Undervalued Names Too Cheap to Ignore Page 2 of 2 ‹ Most Recent12 More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.